Gutierrez and Leslie Discuss Recent Efforts and Future Advances in CAR T-Cell Therapy

Commentary
Podcast

Drs Gutierrez and Leslie discuss common barriers that institutions face when implementing CAR T-cell therapy programs, the early success story of outpatient administration of this modality at John Theurer Cancer Center, and future considerations for using this treatment approach in solid tumors.

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.

OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we had the pleasure of speaking with Martin E. Gutierrez, MD, and Lori A. Leslie, MD, about the use of CAR T-cell therapy in hematologic malignancies and solid tumors.

Dr Gutierrez is the director of the Drug Discovery/Phase I Program, co-chief of Thoracic Oncology at John Theurer Cancer Center, Hackensack University Medical Center, as well as a professor in the Department of Oncology at Hackensack Meridian School of Medicine, both in New Jersey. He is also an associate member of the Thoracic & Gastrointestinal Oncology Program, co-chair of the Phase I Diseases Group, and co-chair of the Protocol Review and Monitoring Committee at Georgetown Lombardi Comprehensive Cancer Center in Washington, DC. Dr Leslie is the director of the Indolent Lymphoma and Chronic Lymphocytic Leukemia Research Programs at John Theurer Cancer Center, Hackensack University Medical Center, as well as an assistant professor at Hackensack Meridian School of Medicine.

In our exclusive interview, Drs Gutierrez and Leslie discussed common barriers that institutions face when implementing CAR T-cell therapy programs, the early success story of outpatient administration of this modality at John Theurer Cancer Center, and future considerations for using this treatment approach in solid tumors.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air®. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive® is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air®.

*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Related Videos
A panel of 4 experts on colorectal cancer
Andrew Ip, MD
Lori A. Leslie, MD, an expert on lymphoma
Lori A. Leslie, MD, an expert on lymphoma
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Andre Goy, MD
Andre Goy, MD
Lori A. Leslie, MD, an expert on lymphoma
Lori A. Leslie, MD, an expert on lymphoma